Table of ContentsPART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: SEGMENTATION BY APPLICATION • Overview • Predictive and diagnostic testing • Prenatal, newborn, and pre-implantation testing • Pharmacogenomic testing • Forensic, relationship, and ancestry testing PART 08: SEGMENTATION BY PRODUCT • Overview • Comparison by product • Analyzers • Consumables • Market opportunity by product PART 09: CUSTOMER LANDSCAPE PART 10: SEGMENTATION BY END-USER • Overview • Clinical diagnostics laboratories • Hospitals • Biopharmaceuticals companies and research centers PART 11: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Genetic testing market in Americas • Genetic testing market in EMEA • Genetic testing market in APAC • Market opportunity PART 12: DECISION FRAMEWORK PART 13: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 14: MARKET TRENDS • Growing demand for companion diagnostics • Availability of NGS for present and future genetic diagnosis • Growing adoption of DTC genetic testing PART 15: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive landscape PART 16: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • bioMérieux • Bio-Rad Laboratories • F. Hoffmann-La Roche • Myriad Genetics • QIAGEN • Quest Diagnostics PART 17: APPENDIX • List of abbreviations Exhibit 01: Parent market: Global IVD market Exhibit 02: Global IVD market: Segments Exhibit 03: Market characteristics Exhibit 04: Global genetic testing market: Segments Exhibit 05: Market definition: Inclusions and exclusions checklist Exhibit 06: Global genetic testing market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global genetic testing market 2017-2022 ($ millions) Exhibit 09: Global genetic testing market: Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition: Five forces 2017 Exhibit 18: Global genetic testing market: Segmentation by application 2017 (% share) Exhibit 19: Global genetic testing market: Segmentation by product 2017-2022 (% share) Exhibit 20: Global genetic testing market: Comparison by product Exhibit 21: Global genetic testing analyzers market 2017-2022 ($ millions) Exhibit 22: Global genetic testing analyzers market: Year-over-year growth 2018-2022 (%) Exhibit 23: Global genetic testing consumables market 2017-2022 ($ millions) Exhibit 24: Global genetic testing consumables market: Year-over-year growth 2018-2022 (%) Exhibit 25: Market opportunity by product Exhibit 26: Customer landscape Exhibit 27: Global genetic testing market: Segmentation by end-user 2017 (% share) Exhibit 28: Global genetic testing market: Segmentation by geography 2017-2022 (% share) Exhibit 29: Regional comparison Exhibit 31: Genetic testing market in Americas 2017-2022 ($ millions) Exhibit 32: Genetic testing market in Americas: Year-over-year growth 2018-2022 (%) Exhibit 33: Top-three countries in Americas Exhibit 34: Genetic testing market in EMEA 2017-2022 ($ millions) Exhibit 35: Genetic testing market in EMEA: Year-over-year growth 2018-2022 (%) Exhibit 36: Top-three countries in EMEA Exhibit 37: Genetic testing market in APAC 2017-2022 ($ millions) Exhibit 38: Genetic testing market in APAC: Year-over-year growth 2018-2022 (%) Exhibit 39: Top-three countries in APAC Exhibit 40: Market opportunity Exhibit 41: Product approvals in few countries and their market impact analysis Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Abbott: Overview Exhibit 48: Abbott: Business segments Exhibit 49: Abbott: Organizational developments Exhibit 50: Abbott: Geographic focus Exhibit 51: Abbott: Segment focus Exhibit 52: Abbott: Key offerings Exhibit 53: Abbott: Key customers Exhibit 54: bioMérieux: Overview Exhibit 55: bioMérieux: Business segments Exhibit 56: bioMérieux: Organizational developments Exhibit 57: bioMérieux: Geographic focus Exhibit 58: bioMérieux: Segment focus Exhibit 59: bioMérieux: Key offerings Exhibit 60: bioMérieux: Key customers Exhibit 61: Bio-Rad Laboratories: Overview Exhibit 62: Bio-Rad Laboratories: Business segments Exhibit 63: Bio-Rad Laboratories: Organizational developments Exhibit 64: Bio-Rad Laboratories: Geographic focus Exhibit 65: Bio-Rad Laboratories: Segment focus Exhibit 66: Bio-Rad Laboratories: Key offerings Exhibit 67: Bio-Rad Laboratories: Key customers Exhibit 68: F. Hoffmann-La Roche: Overview Exhibit 69: F. Hoffmann-La Roche: Business segments Exhibit 70: F. Hoffmann-La Roche: Organizational developments Exhibit 71: F. Hoffmann-La Roche: Geographic focus Exhibit 72: F. Hoffmann-La Roche: Segment focus Exhibit 73: F. Hoffmann-La Roche: Key offerings Exhibit 74: F. Hoffmann-La Roche: Key customers Exhibit 75: Myriad Genetics: Overview Exhibit 76: Myriad Genetics: Business segments Exhibit 77: Myriad Genetics: Organizational developments Exhibit 78: Myriad Genetics: Geographic focus Exhibit 79: Myriad Genetics: Segment focus Exhibit 80: Myriad Genetics: Key offerings Exhibit 81: Myriad Genetics: Key customers Exhibit 82: QIAGEN: Overview Exhibit 83: QIAGEN: Product categories Exhibit 84: QIAGEN: Organizational developments Exhibit 85: QIAGEN: Geographic focus Exhibit 86: QIAGEN: Product categories focus Exhibit 87: QIAGEN: Key offerings Exhibit 88: QIAGEN: Key customers Exhibit 89: Quest Diagnostics: Overview Exhibit 90: Quest Diagnostics: Business segments Exhibit 91: Quest Diagnostics: Organizational developments Exhibit 92: Quest Diagnostics: Geographic focus Exhibit 93: Quest Diagnostics Segment focus Exhibit 94: Quest Diagnostics Key offerings Exhibit 95: Quest Diagnostics: Key customers

Abbott bioMérieux Bio-Rad Laboratories F. Hoffmann-La Roche Myriad Genetics QIAGEN Quest Diagnostics